Inpatient IBD Care: Practical Guidance From the AGA- Gastroenterology Feb.26

Introduction

Despite major advances in outpatient therapies, hospitalisation for inflammatory bowel disease (IBD) remains common and challenging. Outcomes vary widely, with persistent problems such as:

hospital-acquired complications,

delays in appropriate surgery, and

high 30-day readmission rates.

To reduce this variability and improve outcomes, the American Gastroenterological Association (AGA) released this Clinical Practice Update to provide clear, pragmatic Best Practice Advice for the inpatient management of adults with ulcerative colitis (UC) and Crohn’s disease (CD).

What this document is (and is not)

This is an expert review, not a formal guideline.

Recommendations are based on best available evidence plus expert consensus.

The focus is on real-world inpatient decision-making, not exhaustive literature grading.

Core principles that shape inpatient IBD care

1️⃣ Admit early when risk is high

Hospitalization should be considered for patients with:

severe disease refractory to outpatient therapy,

suspected complications (obstruction, abscess, perforation), or

significant malnutrition, anemia, or failure to thrive.

The modern inpatient population increasingly includes patients failing multiple advanced therapies, not just classic fulminant presentations.

2️⃣ Start with supportive care—but do it well

All hospitalised IBD patients should receive:

IV fluids and electrolyte correction,

anaemia and nutrition assessment (early dietitian involvement),

careful pain control (avoid routine opioids),

screening for vitamin and iron deficiency.

Supportive care is not ancillary—it directly affects outcomes.

3️⃣ Always rule out infection and complications

Symptoms in hospitalised IBD patients are frequently driven by:

C. difficile,

CMV colitis, or

structural complications.

Early stool testing, cross-sectional imaging when indicated, and targeted endoscopy are essential to avoid inappropriate escalation of immunosuppression.

4️⃣ Use objective disease assessment

CRP is emphasised as a real-time inflammatory marker guiding decisions.

Endoscopic evaluation (often flexible sigmoidoscopy) should be performed early when feasible, both to assess severity and to obtain biopsies for CMV.

Faecal calprotectin may help, but is often delayed in the inpatient setting.

5️⃣ Prevent what is preventable: VTE prophylaxis

Hospitalised IBD patients have a markedly increased risk of venous thromboembolism.

👉 All hospitalised IBD patients without contraindications should receive pharmacologic VTE prophylaxis, even in the presence of active bleeding.

Disease-specific highlights

Acute Severe Ulcerative Colitis (ASUC)

IV corticosteroids remain first-line therapy.

Response must be assessed within 72 hours using stool frequency and CRP trends.

Nonresponse requires early preparation for rescue therapy (infliximab, cyclosporine, or JAK inhibitors) and early surgical consultation.

Continuing IV steroids beyond 7 days without response offers no benefit and increases harm.

Crohn’s Disease–Related Complications

Obstruction:

If inflammatory → trial IV steroids.

If fibrotic or complicated → surgery.

Intra-abdominal abscess:

Drainage (when feasible) + antibiotics first.

Immunosuppression only after source control.

Perianal disease:

Requires a multidisciplinary medical–surgical approach from the outset.

6️⃣ Plan discharge early—and deliberately

Safe discharge requires:

clinical stability (not necessarily normal labs),

a clear steroid taper or induction plan,

coordination with outpatient providers, and

addressing barriers such as insurance approval, transportation, and infusion scheduling.

Poor discharge planning is a major driver of readmissions.

Why this update matters

This document reinforces a shift in inpatient IBD care:

from reactive, prolonged hospitalisations

to structured, time-bound decision-making with early reassessment, escalation, or surgery.

It emphasises that delays—not disease severity alone—often drive poor outcomes.

Bottom-line takeaway:

High-quality inpatient IBD care depends on early objective assessment, proactive complication management, timely escalation or surgery, and meticulous discharge planning. This AGA update provides a practical roadmap for achieving that consistently.

One-line GastroAGI takeaway:

In inpatient IBD care, timing and coordination matter as much as therapy choice.